AbbVie has announced plans to release its second-quarter 2025 financial results on July 31, 2025. The announcement will occur before the market opens. Following this, AbbVie will conduct a live webcast of its earnings conference call at 8 a.m. Central time. Interested parties can access the webcast through AbbVie's Investor Relations website at investors.abbvie.com. For those unable to attend live, an archived version of the session will be available later in the day.
AbbVie is focused on discovering and delivering innovative medicines and solutions for serious health issues while addressing future medical challenges. The company aims to make a significant impact across various therapeutic areas including immunology, oncology, neuroscience, and eye care, along with products and services in their Allergan Aesthetics portfolio.
For further information about AbbVie, visit www.abbvie.com or follow them on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media inquiries can be directed to Gabby Tarbert at (224) 244-0111 or via email at gabrielle.tarbert@abbvie.com. Investors may contact Liz Shea at (847) 935-2211 or liz.shea@abbvie.com.
###